AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteBortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBosentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
More Information Supplier PageBosentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
More Information Supplier PageBosentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
More Information Supplier PageBosentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
More Information Supplier PageBosentan is a competitive antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
More Information Supplier PageBosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageBosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageBosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageBosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageBosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageBP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
More Information Supplier PageBP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
More Information Supplier PageBP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
More Information Supplier PageBP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
More Information Supplier PageBQ-788 sodium salt is a selective ETBR (Endothelin receptor B ) antagonist.
More Information Supplier PageBQ-788 sodium salt is a selective ETBR (Endothelin receptor B ) antagonist.
More Information Supplier PageBQ-788 sodium salt is a selective ETBR (Endothelin receptor B ) antagonist.
More Information Supplier PageBrassinolide is a plant sterol first isolated from pollen of rape (Brassica napus L.), Brassinolide could promote stem elongation and cell division.
More Information Supplier PageBrassinolide is a plant sterol first isolated from pollen of rape (Brassica napus L.), Brassinolide could promote stem elongation and cell division.
More Information Supplier PageBrassinolide is a plant sterol first isolated from pollen of rape (Brassica napus L.), Brassinolide could promote stem elongation and cell division.
More Information Supplier PageEnhances differentiation of induced pluripotent stem cells (iPSCs) to hepatocytes; also promotes the maturation of iPSC-derived hepatocytes.
More Information Supplier PageEnhances differentiation of induced pluripotent stem cells (iPSCs) to hepatocytes; also promotes the maturation of iPSC-derived hepatocytes.
More Information Supplier PageEnhances differentiation of induced pluripotent stem cells (iPSCs) to hepatocytes; also promotes the maturation of iPSC-derived hepatocytes.
More Information Supplier PageEnhances differentiation of induced pluripotent stem cells (iPSCs) to hepatocytes; also promotes the maturation of iPSC-derived hepatocytes.
More Information Supplier PageBRD73954 is a small molecule inhibitor that potently inhibits both HDAC6 and HDAC8 (IC50s = 36 and 120 nM, respectively).
More Information Supplier PageBRD73954 is a small molecule inhibitor that potently inhibits both HDAC6 and HDAC8 (IC50s = 36 and 120 nM, respectively).
More Information Supplier PageBRD73954 is a small molecule inhibitor that potently inhibits both HDAC6 and HDAC8 (IC50s = 36 and 120 nM, respectively).
More Information Supplier PageBRD9757 is a highly potent and selective HDAC6 inhibitor with an IC50 of 30 nM toward HDAC6.
More Information Supplier PageBRD9757 is a highly potent and selective HDAC6 inhibitor with an IC50 of 30 nM toward HDAC6.
More Information Supplier PageBRD9757 is a highly potent and selective HDAC6 inhibitor with an IC50 of 30 nM toward HDAC6.
More Information Supplier PageBRD9757 is a highly potent and selective HDAC6 inhibitor with an IC50 of 30 nM toward HDAC6.
More Information Supplier Page
